Newsstand Menu

Home / Newsstand / CSHL Stories and Media / LabDish Blog

CSHL Story and Media archive for Tag: Lloyd Trotman

Filter by tag

photo of Lloyd Trotman speaking to crowd for Cocktails & Chromosomes Movember

Fresh insights into prostate cancer surprise Movember crowd

11/22/2019

For a special “Movember” edition of Cocktails and Chromosomes, Dr. Lloyd Trotman explained what his lab is doing to understand deadly prostate cancers. Read the story »

photo of Lloyd Trotman from Cocktails & Chromosomes

Movember with Lloyd Trotman—A Cocktails and Chromosomes talk about prostate cancer

11/19/2019

In this Movember edition of Cocktails & Chromosomes, learn how new concepts of cancer evolution could turn prostate cancer into a curable disease. Watch the video »

Enzyme PHLPP2 could be a viable drug target for treating prostate cancer

5/15/2019

Researchers have identified an enzyme called Phlpp2 as an attractive drug target for treating prostate cancer. Read the story »

One experiment: Observing cancer’s progress in a mouse prostate

3/14/2019

Using a technique originally designed for mapping brains, two CSHL labs have worked together to image cancer progression in a mouse prostate. Read the story »

Study reveals a way to make prostate cancer cells run out of energy and die

4/3/2018

In lethal prostate cancer, the gene PTEN is often missing. In such cases, one effective treatment may be to administer drugs that inhibit mitochondria Read the story »

Researchers identify “Achilles’ heel” of PTEN that helps drive prostate cancer progression

2/13/2017

Researchers at CSHL have discovered that a protein called Importin-11 protects the anti-cancer protein PTEN from destruction by transporting it. Read the story »

No (real) moustache required to join the “Movember” party

11/15/2016

Members of Trotman don fake moustaches in order to raise money for prostate cancer research during Movember. Read the story »

Movember: Fighting for health in the Lab and the gym

11/20/2015

Dawid Nowak discusses the difficulties and challenges involved in understanding pancreatic cancer. Read the story »

Third-year student Abram Handly Santana explores the pancreatic tumor microenvironment

8/1/2015

Abram Handly Santana wants to understand how the tumor microenvironment contributes to pancreas cancer. Read the story »

An immune system marker for therapy-resistant prostate cancer

6/4/2015

Research shows how signaling by an immune system component appears to play an important role in driving particularly aggressive prostate cancer Read the story »

Pershing Square Foundation establishes $10 million endowment to support CSHL life science research

6/1/2015

The uniquely structured grant reflects a commitment by The Pershing Square Foundation to support exceptional leadership and innovative organizations. Read the story »

Study revises standard theory of how PTEN, a critical tumor suppressor, shuts off growth signals

4/9/2015

Scientists discover new evidence explaining precisely how the protein encoded by PTEN (called PTEN) works Read the story »

One experiment: Cellular highways carry anti-cancer cargoes

4/9/2015

The gene called PTEN is one of the most important of the body’s natural tumor suppressors. Read the story »

A novel biomarker for mutant p53 could help pathologists assessing tumors during surgery

1/5/2015

New discovery may make it easy for cancer surgeons to determine if a patient has a potentially lethal mutation. Read the story »

Lloyd Trotman receives Pershing Square Sohn Prize for Cancer Research

5/5/2014

Associate Professor Award encourages young investigators to take risks in search of a cure Read the story »